Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now
In a new and very comprehensive report, Jefferies starts coverage on biotechs with some very targeted stock selections.
In a new and very comprehensive report, Jefferies starts coverage on biotechs with some very targeted stock selections.
Monday's top analyst upgrades, downgrades and initiations include Exxon Mobil, Home Depot, Lululemon Athletica, 3M, Vodafone, Mondelez International and Chevron.
A new research note from SunTrust Robinson Humphrey mentions four stocks that they think could possibly get swept up in the biotech M&A excitement.
Here are three biotech stocks that a SunTrust analyst feels could be buyout candidates, in the wake of the Pharmacyclics acquisition.
In a trend that seems somewhat locked into place, insiders continue to sell stock, though as we have seen most of this year, nobody is rushing to the exits, at least for…
Agenus, in conjunction with Incyte, announced a global license for the development and commercialization of Agenus's proprietary Retrocyte Display antibody discovery platform.
At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks.
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Friday, October 31, 2014.
Incyte has serious upside potential, but the inherent risk within it may be too much for some investors to bear.
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. for Wednesday, September 17, 2014.
SunTrust Robinson Humphrey opens up coverage of the biotech sector with four top biotech stocks to buy and one Neutral-rated stock.
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit the tape.
A new research report from Cowen cautions that progress on a cure for pancreatic cancer is slow, but steady. Drugs from three companies though have been favorably viewed by consultants.
ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance at the American Society of Clinical Oncology yearly conference. Many of the…
Here are the top analyst upgrades, downgrades and initiations seen from Wall Street on Tuesday, April 29, 2014. They include Buffalo Wild Wings, Coca-Cola, DSW and Intuitive Surgical.